Minoru Fujimoto

7PUBLICATIONS
14CO-AUTHORS
AutoimmunityMolecular targetsInstrumental methods (excl. immunological and bioassay methods)Foetal development and medicineNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 07, 2025
A Role for Leucine-Rich α2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.

Takashi Mishima, Minoru Fujimoto, Hayato Urushima

|Sep 29, 2021
Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.

Shigehiro Tsujii, Satoshi Serada, Minoru Fujimoto

|Mar 02, 2021
The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein.

Hideki Nakajima, Kimiko Nakajima, Mikiro Takaishi

|Nov 19, 2020
Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection.

Etsuko Kajimoto, Masayuki Endo, Minoru Fujimoto

|Jun 24, 2018
NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation.

Akihiro Kimura, Masayuki Kitajima, Kyoko Nishida

Pageof 2